子宫颈癌前哨淋巴结活检临床应用中国专家共识  

Expert consensus on clinical application of sentinel lymph node biopsy for cervical cancer

作　　者：中国研究型医院学会妇产科学专业委员会 李斌 王建六[3] 胡元晶[4] 陈晓军 宋艳 沈丹华[7] Obstetrics and Gynecology Committee of Chinese Research Hospital Association;Li Bin;Wang Jianliu(不详;Department of Gynecology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Obstetrics and Gynecology,Peking University People's Hospitaly Beijing 100044,China)

机构地区：[1]不详 [2]国家癌症中心,国家肿瘤临床医学研究中心,中国医学科学院北京协和医学院肿瘤医院妇科,100021 [3]北京大学人民医院妇产科,100044 [4]天津市中心妇产科医院妇瘤科 [5]复旦大学附属妇产科医院妇科 [6]国家癌症中心,国家肿瘤临床医学研究中心,中国医学科学院北京协和医学院肿瘤医院病理科 [7]北京大学人民医院病理科

出　　处：《中华肿瘤杂志》2021年第10期981-988,共8页Chinese Journal of Oncology

基　　金：首都卫生发展科研专项(2020-2-4024)。

摘　　要：子宫颈癌是妇科常见的恶性肿瘤。大多数早期子宫颈癌患者接受了不必要的系统盆腔淋巴结切除,增加了手术并发症的风险。目前,前哨淋巴结活检在国外已经应用于子宫颈癌的临床实践,但在中国尚处于起步阶段,亟需应用和推广。中国研究型医院学会妇产科学专业委员会邀请中国妇科肿瘤领域专家,基于当前研究现状,对子宫颈癌前哨淋巴结活检的应用价值、患者评估、技术方法、操作要点、病理检测等诸多关键性问题进行探讨,达成子宫颈癌前哨淋巴结活检临床应用中国专家共识,以指导子宫颈癌前哨淋巴结活检在中国的规范化开展。Cervical cancer is a common gynecologic malignancy.Most patients with early-stage cervical cancer received unnecessary systemic pelvic lymphadenectomy,which increased the risk of surgical complications.At present,sentinel lymph node biopsy has been applied in the clinical practice of cervical cancer abroad,however it is still at the starting stage in China in need of application and promotion.The Obstetrics and Gynecology Committee of Chinese Research Hospital Association invited domestic experts in the field of gynecologic oncology to discuss the application value,patient evaluation,technical methods,operation steps,pathological examination and many other key points of sentinel lymph node biopsy based on the current research status,and reached the consensus of clinical application on sentinel lymph node biopsy in cervical cancer to guide the standardized application of the technique in China.

关 键 词：子宫颈肿瘤 前哨淋巴结活检 前哨淋巴结诊断准确性 临床应用 专家共识 

分 类 号：R737.33[医药卫生—肿瘤]